EventsThe 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published
This submission belongs to the session S9. Formulation, Drug Delivery, and Controlled Release of the event The 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published date
28 Oct, 2026
Academic Editor
author-avatarThierry Vandamme
Contribution&Funding
Validation,
[Carla Lopes] ; [Maria Helena Amaral]
Formal analysis,
[Rita Loureiro Carneiro]
Investigation,
[Rita Loureiro Carneiro]
Resources,
[Marlene Lúcio] ; [Maria Helena Amaral]
Data curation,
[Rita Loureiro Carneiro]
Writing - original draft,
[Rita Loureiro Carneiro]
Writing - review,
[editing] ; [Carla Lopes] ; [Marlene Lúcio] ; [Maria Helena Amaral]
Visualization,
[Carla Lopes] ; [Maria Helena Amaral]
Supervision,
[Carla Lopes] ; [Maria Helena Amaral]
Project administration,
[Maria Helena Amaral]
Funding: --
Citation
Rita Loureiro Carneiro, Carla Lopes, Marlene Lúcio, Maria Helena Amaral, Development and characterization of an innovative two-component film-spray system for topical administration of hydroquinone., in Proceedings of The 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics, 1 November–30 November 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Development and characterization of an innovative two-component film-spray system for topical administration of hydroquinone.

image
image
1. UCIBIO i4HB, MEDTECH - Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Porto, 4050-313, Portugal
2. RISE HEALTH, Faculty of Health Science, Fernando Pessoa University, Porto, Portugal
3. CF-UM-UP – Centre of Physics of University of Minho and Porto; LAPMET – Laboratory of Physics for Materials and Emerging Technologies; CBMA – Centre of Molecular and Environmental Biology, University of Minho, Braga, Portugal
Abstract

Hydroquinone (HQ) remains the gold-standard topical agent for skin hyperpigmentation disorders, but its clinical use is limited by pronounced physicochemical instability, particularly its high susceptibility to oxidative degradation. To overcome this limitation, an innovative two-component delivery system was developed, combining a polyvinyl alcohol (PVA)/glycerin polymeric film with an HQ solution applied as a spray, designed to minimize the exposure of HQ to oxidative effects. Three film formulations with varying PVA concentrations (1.5- 3%) were screened based on thickness, mass uniformity, and mechanical resistance. The 2.0% PVA formulation was selected and further optimized by reducing the glycerin content to 0.7%, yielding a uniform, mechanically stable film with adequate thickness (0.1800.022 mm), water absorption (108.875.09%), and surface pH (6.510.23) for topical use. The optimized HQ spray (2% HQ, 0.2% sodium metabisulfite, and purified water) delivered a consistent dose of 1.85 mg HQ/cm2 per standardized application (five actuations over 4 cm2). Over a 28-day stability study, refrigeration (4ºC) of HQ solution markedly limited HQ oxidation compared with storage at 25ºC (2.2% vs. 7.6% degradation), a trend paralleled by the pH profiles. Upon combination, spray application onto the film produced a slight, favorable decrease in surface pH (6.180.16), and ATR-FTIR analysis confirmed successful HQ incorporation into the polymeric matrix without major chemical alterations, consistent with predominantly physical incorporation and/or hydrogen-bonding interactions. These results support the two-component film-spray system as a promising strategy to overcome the oxidative instability of conventional HQ formulations, offering a novel approach for the topical delivery of oxidation-prone actives. 

Keywords
Hydroquinone
Oxidative stability
Polyvinyl alcohol film
Spray delivery
Two-component drug delivery system
Narrowing the Experimental Space: Quality by Design-Guided Early-Stage Development of Lipid–Polymer Hybrid Nanoparticles
FORMULATION AND EVALUATION OF SELF-MICRO EMULSIFYING DRUG DELIVERY SYSTEM OF ATORVASTATIN CALCIUM